Senestech Return on Investment 2015-2025 | SNES
Senestech ROI - Return on Investment Historical Data | |||
---|---|---|---|
Date | TTM Net Income | LT Investments & Debt | Return on Investment |
2025-03-31 | $-0.01B | $0.00B | -215.38% |
2024-12-31 | $-0.01B | $0.00B | -186.67% |
2024-09-30 | $-0.01B | $0.00B | -168.42% |
2024-06-30 | $-0.01B | $0.00B | -177.78% |
2024-03-31 | $-0.01B | $0.01B | -213.33% |
2023-12-31 | $-0.01B | $0.01B | -320.00% |
2023-09-30 | $-0.01B | $0.00B | -1066.67% |
2023-06-30 | $-0.01B | 0.00% | |
2023-03-31 | $-0.01B | 0.00% | |
2022-12-31 | $-0.01B | 0.00% | |
2022-09-30 | $-0.01B | 0.00% | |
2022-06-30 | $-0.01B | 0.00% | |
2022-03-31 | $-0.01B | 0.00% | |
2021-12-31 | $-0.01B | -188.24% | |
2021-09-30 | $-0.01B | -145.45% | |
2021-06-30 | $-0.01B | -123.08% | |
2021-03-31 | $-0.01B | $0.02B | -100.00% |
2020-12-31 | $-0.01B | $0.01B | -188.24% |
2020-09-30 | $-0.01B | $0.00B | -240.00% |
2020-06-30 | $-0.01B | $0.01B | -250.00% |
2020-03-31 | $-0.01B | $0.00B | -285.71% |
2019-12-31 | $-0.01B | $0.00B | -250.00% |
2019-09-30 | $-0.01B | $0.01B | -200.00% |
2019-06-30 | $-0.01B | $0.00B | -150.00% |
2019-03-31 | $-0.01B | $0.00B | -169.23% |
2018-12-31 | $-0.01B | $0.01B | -171.43% |
2018-09-30 | $-0.01B | $0.01B | -151.72% |
2018-06-30 | $-0.01B | $0.01B | -200.00% |
2018-03-31 | $-0.01B | $0.01B | -200.00% |
2017-12-31 | $-0.01B | $0.01B | -177.78% |
2017-09-30 | $-0.01B | $0.00B | -186.67% |
2017-06-30 | $-0.01B | $0.01B | -207.41% |
2017-03-31 | $-0.01B | $0.01B | -228.57% |
2016-12-31 | $-0.01B | $0.01B | -366.67% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $0.010B | $0.002B |
SenesTech, Inc. developed technology for managing animal pest populations through fertility control as opposed to a lethal approach. The Company's fertility control product candidate, ContraPest(R), will be marketed for use initially in controlling rat infestations. SenesTech, Inc. is based in Flagstaff, Arizona. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $236.635B | 28.45 |
Boston Scientific (BSX) | United States | $158.907B | 39.78 |
Stryker (SYK) | United States | $151.008B | 31.58 |
EssilorLuxottica (ESLOY) | France | $127.124B | 0.00 |
Medtronic (MDT) | Ireland | $111.799B | 15.85 |
Lonza Group Ag (LZAGY) | Switzerland | $51.541B | 0.00 |
Haleon (HLN) | United Kingdom | $46.605B | 26.59 |
ResMed (RMD) | United States | $37.830B | 28.41 |
GE HealthCare Technologies (GEHC) | United States | $33.916B | 16.10 |
Agilent Technologies (A) | United States | $33.522B | 21.85 |
Terumo (TRUMY) | Japan | $27.168B | 35.29 |
Koninklijke Philips (PHG) | Netherlands | $23.091B | 16.20 |
Insulet (PODD) | United States | $22.110B | 86.79 |
Zimmer Biomet Holdings (ZBH) | United States | $18.046B | 11.59 |
Baxter (BAX) | United States | $15.539B | 11.60 |
Smith & Nephew SNATS (SNN) | United Kingdom | $13.415B | 0.00 |
Demant (WILYY) | Denmark | $9.110B | 0.00 |
Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
Bio-Rad Laboratories (BIO) | United States | $6.567B | 22.85 |
Lantheus Holdings (LNTH) | United States | $5.664B | 14.29 |
Prestige Consumer Healthcare (PBH) | United States | $3.946B | 17.63 |
Perrigo (PRGO) | Ireland | $3.673B | 9.31 |
Haemonetics (HAE) | United States | $3.584B | 16.33 |
Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
Envista Holdings (NVST) | United States | $3.312B | 27.52 |
ICU Medical (ICUI) | United States | $3.252B | 23.98 |
QuidelOrtho (QDEL) | United States | $1.949B | 13.40 |
LeMaitre Vascular (LMAT) | United States | $1.876B | 41.94 |
AtriCure (ATRC) | United States | $1.622B | 0.00 |
Acuren (TIC) | United States | $1.341B | 0.00 |
AdaptHealth (AHCO) | United States | $1.273B | 12.92 |
Green Thumb Industries (GTBIF) | United States | $1.167B | 26.24 |
Neogen (NEOG) | United States | $1.037B | 13.28 |
Phibro Animal Health (PAHC) | United States | $1.035B | 13.23 |
BioLife Solutions (BLFS) | United States | $1.023B | 0.00 |
InMode (INMD) | Israel | $0.913B | 9.20 |
Kestra Medical Technologies (KMTS) | United States | $0.851B | 0.00 |
Owens & Minor (OMI) | United States | $0.703B | 5.83 |
CeriBell (CBLL) | United States | $0.677B | 0.00 |
Maravai LifeSciences Holdings (MRVI) | United States | $0.614B | 0.00 |
Evolus (EOLS) | United States | $0.594B | 0.00 |
Curaleaf Holdings (CURLF) | Canada | $0.559B | 0.00 |
Valneva SE (VALN) | France | $0.482B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.454B | 0.00 |
Surmodics (SRDX) | United States | $0.425B | 0.00 |
Tilray Brands (TLRY) | Canada | $0.417B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.357B | 13.14 |
Quanterix (QTRX) | United States | $0.332B | 0.00 |
SNDL (SNDL) | Canada | $0.318B | 0.00 |
SEMPERIT AG HLD (SEIGY) | Austria | $0.301B | 0.00 |
Sanuwave Health (SNWV) | United States | $0.281B | 0.00 |
Viemed Healthcare (VMD) | United States | $0.273B | 23.03 |
Cerus (CERS) | United States | $0.270B | 0.00 |
ZimVie (ZIMV) | United States | $0.260B | 11.84 |
Sanara MedTech (SMTI) | United States | $0.252B | 0.00 |
Cresco Labs (CRLBF) | United States | $0.252B | 0.00 |
Brainsway (BWAY) | Israel | $0.248B | 65.75 |
Aurora Cannabis (ACB) | Canada | $0.238B | 70.67 |
OraSure Technologies (OSUR) | United States | $0.224B | 0.00 |
Canopy Growth (CGC) | Canada | $0.224B | 0.00 |
Biote (BTMD) | United States | $0.220B | 6.18 |
TriSalus Life Sciences (TLSI) | United States | $0.206B | 0.00 |
High Tide (HITI) | Canada | $0.187B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.185B | 15.06 |
Organigram Global (OGI) | Canada | $0.181B | 0.00 |
Verano Holdings (VRNOF) | United States | $0.180B | 0.00 |
Omeros (OMER) | United States | $0.176B | 0.00 |
Exagen (XGN) | United States | $0.149B | 0.00 |
Vireo Growth (VREOF) | United States | $0.143B | 0.00 |
FitLife Brands (FTLF) | United States | $0.122B | 15.05 |
Jin Medical (ZJYL) | China | $0.102B | 0.00 |
Fonar (FONR) | United States | $0.093B | 11.97 |
Oramed Pharmaceuticals (ORMP) | United States | $0.092B | 0.00 |
TerrAscend (TSNDF) | Canada | $0.085B | 0.00 |
Veru (VERU) | United States | $0.085B | 0.00 |
Apyx Medical (APYX) | United States | $0.085B | 0.00 |
Cytosorbents (CTSO) | United States | $0.080B | 0.00 |
Zynex (ZYXI) | United States | $0.078B | 0.00 |
Quipt Home Medical (QIPT) | United States | $0.078B | 0.00 |
MacroGenics (MGNX) | United States | $0.076B | 0.00 |
InterCure (INCR) | Israel | $0.067B | 0.00 |
Agape ATP (ATPC) | $0.066B | 0.00 | |
Jushi Holdings (JUSHF) | United States | $0.064B | 0.00 |
ImmuCell (ICCC) | United States | $0.063B | 0.00 |
Nephros (NEPH) | United States | $0.043B | 58.43 |
Modular Medical (MODD) | United States | $0.040B | 0.00 |
United-Guardian (UG) | United States | $0.037B | 12.70 |
Rockwell Medical (RMTI) | United States | $0.029B | 0.00 |
Safety Shot (SHOT) | United States | $0.025B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.018B | 0.00 |
INLIF (INLF) | $0.017B | 0.00 | |
Flora Growth (FLGC) | United States | $0.013B | 0.00 |
Cellectar Biosciences (CLRB) | United States | $0.013B | 0.00 |
Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
Akanda (AKAN) | Canada | $0.002B | 0.00 |
Sharps Technology (STSS) | United States | $0.000B | 0.00 |
InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |